

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of apoptotic cell clearance (GO:2000425) | 7.75557076 |
| 2 | regulation of integrin activation (GO:0033623) | 6.89884373 |
| 3 | lipoxygenase pathway (GO:0019372) | 6.29168265 |
| 4 | apoptotic cell clearance (GO:0043277) | 6.10087999 |
| 5 | cellular extravasation (GO:0045123) | 6.09867884 |
| 6 | mannose metabolic process (GO:0006013) | 6.09153601 |
| 7 | production of molecular mediator involved in inflammatory response (GO:0002532) | 5.64214069 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 5.31290519 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 5.31290519 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.31290519 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.31290519 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.31290519 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 5.31290519 |
| 14 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.97275180 |
| 15 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 4.95517751 |
| 16 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.90952951 |
| 17 | complement activation, alternative pathway (GO:0006957) | 4.79461961 |
| 18 | neutrophil activation involved in immune response (GO:0002283) | 4.76551097 |
| 19 | leukotriene metabolic process (GO:0006691) | 4.70099469 |
| 20 | germinal center formation (GO:0002467) | 4.63267116 |
| 21 | respiratory burst (GO:0045730) | 4.63109743 |
| 22 | detection of molecule of bacterial origin (GO:0032490) | 4.52300174 |
| 23 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.50112458 |
| 24 | negative regulation of cell killing (GO:0031342) | 4.50112458 |
| 25 | negative regulation of granulocyte differentiation (GO:0030853) | 4.34603546 |
| 26 | response to peptidoglycan (GO:0032494) | 4.25730226 |
| 27 | negative regulation of interleukin-12 production (GO:0032695) | 4.18190825 |
| 28 | regulation of T cell chemotaxis (GO:0010819) | 4.13607911 |
| 29 | positive regulation of T cell chemotaxis (GO:0010820) | 4.13607911 |
| 30 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.02596567 |
| 31 | positive regulation of mast cell activation (GO:0033005) | 3.96276773 |
| 32 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 3.95497206 |
| 33 | regulation of macrophage chemotaxis (GO:0010758) | 3.91662431 |
| 34 | macrophage activation involved in immune response (GO:0002281) | 3.89456417 |
| 35 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.89099204 |
| 36 | endothelial cell chemotaxis (GO:0035767) | 3.86485623 |
| 37 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.85110895 |
| 38 | regulation of phagocytosis (GO:0050764) | 3.84190954 |
| 39 | citrulline biosynthetic process (GO:0019240) | 3.77429861 |
| 40 | glycosphingolipid catabolic process (GO:0046479) | 3.76665659 |
| 41 | detection of other organism (GO:0098543) | 3.74834614 |
| 42 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.71349693 |
| 43 | regulation of mast cell degranulation (GO:0043304) | 3.70617204 |
| 44 | regulation of T cell migration (GO:2000404) | 3.69997193 |
| 45 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.61588900 |
| 46 | positive regulation of mast cell degranulation (GO:0043306) | 3.61588900 |
| 47 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.57302605 |
| 48 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.56287367 |
| 49 | response to muramyl dipeptide (GO:0032495) | 3.54933012 |
| 50 | opsonization (GO:0008228) | 3.53640100 |
| 51 | regulation of mononuclear cell migration (GO:0071675) | 3.52080172 |
| 52 | T-helper 1 type immune response (GO:0042088) | 3.51759158 |
| 53 | positive regulation of antigen processing and presentation (GO:0002579) | 3.51725977 |
| 54 | oligosaccharide catabolic process (GO:0009313) | 3.51135070 |
| 55 | activated T cell proliferation (GO:0050798) | 3.49923147 |
| 56 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.48837650 |
| 57 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.48830531 |
| 58 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.47128525 |
| 59 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.46702902 |
| 60 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.44991256 |
| 61 | leukocyte cell-cell adhesion (GO:0007159) | 3.43148905 |
| 62 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.42054829 |
| 63 | regulation of gamma-delta T cell activation (GO:0046643) | 3.39396429 |
| 64 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.39021584 |
| 65 | response to host immune response (GO:0052572) | 3.39021584 |
| 66 | negative regulation of interleukin-6 production (GO:0032715) | 3.37683300 |
| 67 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.36025473 |
| 68 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.36025473 |
| 69 | glycolipid catabolic process (GO:0019377) | 3.35393608 |
| 70 | detection of bacterium (GO:0016045) | 3.34943056 |
| 71 | regulation of lymphocyte migration (GO:2000401) | 3.32857903 |
| 72 | immunoglobulin mediated immune response (GO:0016064) | 3.30027837 |
| 73 | regulation of mast cell activation (GO:0033003) | 3.29950027 |
| 74 | response to fungus (GO:0009620) | 3.29913770 |
| 75 | amino sugar catabolic process (GO:0046348) | 3.29899310 |
| 76 | regulation of leukocyte degranulation (GO:0043300) | 3.27608718 |
| 77 | pinocytosis (GO:0006907) | 3.27251413 |
| 78 | cytokine production involved in immune response (GO:0002367) | 3.25707358 |
| 79 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.25532365 |
| 80 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.25125732 |
| 81 | response to host (GO:0075136) | 3.25125732 |
| 82 | response to host defenses (GO:0052200) | 3.25125732 |
| 83 | positive regulation of leukocyte degranulation (GO:0043302) | 3.22995639 |
| 84 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.21013291 |
| 85 | detection of biotic stimulus (GO:0009595) | 3.15837024 |
| 86 | lymphocyte chemotaxis (GO:0048247) | 3.15634205 |
| 87 | neutrophil chemotaxis (GO:0030593) | 3.15521688 |
| 88 | microglial cell activation (GO:0001774) | 3.15429941 |
| 89 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.13754407 |
| 90 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.11721607 |
| 91 | regulation of antigen processing and presentation (GO:0002577) | 3.10493923 |
| 92 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.09622615 |
| 93 | leukotriene biosynthetic process (GO:0019370) | 3.09033828 |
| 94 | positive regulation of interferon-alpha production (GO:0032727) | 3.08078486 |
| 95 | negative regulation of phagocytosis (GO:0050765) | 3.08045003 |
| 96 | positive regulation of T cell migration (GO:2000406) | 3.07535409 |
| 97 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.06927916 |
| 98 | neutrophil migration (GO:1990266) | 3.05701948 |
| 99 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.05328570 |
| 100 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.04313483 |
| 101 | myeloid cell activation involved in immune response (GO:0002275) | 3.02981445 |
| 102 | detection of external biotic stimulus (GO:0098581) | 3.02786118 |
| 103 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.02172993 |
| 104 | neutrophil activation (GO:0042119) | 3.01063151 |
| 105 | fatty acid derivative biosynthetic process (GO:1901570) | 3.00693230 |
| 106 | icosanoid biosynthetic process (GO:0046456) | 3.00693230 |
| 107 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.99935640 |
| 108 | neutrophil mediated immunity (GO:0002446) | 2.99186915 |
| 109 | myeloid dendritic cell differentiation (GO:0043011) | 2.98918945 |
| 110 | regulation of cholesterol storage (GO:0010885) | 2.98665835 |
| 111 | B cell mediated immunity (GO:0019724) | 2.98111716 |
| 112 | response to protozoan (GO:0001562) | 2.97736963 |
| 113 | ceramide catabolic process (GO:0046514) | 2.97199365 |
| 114 | leukocyte tethering or rolling (GO:0050901) | 2.97090943 |
| 115 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.96672252 |
| 116 | macrophage activation (GO:0042116) | 2.96408481 |
| 117 | defense response to protozoan (GO:0042832) | 2.96289912 |
| 118 | defense response to fungus (GO:0050832) | 2.94961450 |
| 119 | positive regulation of phagocytosis (GO:0050766) | 2.94925028 |
| 120 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.94440096 |
| 121 | phagocytosis (GO:0006909) | 2.94432367 |
| 122 | regulation of podosome assembly (GO:0071801) | 2.92074040 |
| 123 | positive regulation of type 2 immune response (GO:0002830) | 2.91990919 |
| 124 | response to laminar fluid shear stress (GO:0034616) | 2.91539967 |
| 125 | regulation of macrophage cytokine production (GO:0010935) | 2.90699568 |
| 126 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.90181768 |
| 127 | regulation of interferon-alpha production (GO:0032647) | 2.89690349 |
| 128 | granulocyte activation (GO:0036230) | 2.89543177 |
| 129 | myeloid dendritic cell activation (GO:0001773) | 2.89172870 |
| 130 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.88932280 |
| 131 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.88147518 |
| 132 | regulation of T cell tolerance induction (GO:0002664) | 2.87173369 |
| 133 | production of molecular mediator of immune response (GO:0002440) | 2.86834227 |
| 134 | positive regulation of Rap GTPase activity (GO:0032854) | 2.86681472 |
| 135 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.85221505 |
| 136 | NIK/NF-kappaB signaling (GO:0038061) | 2.85051639 |
| 137 | leukocyte aggregation (GO:0070486) | 2.84716737 |
| 138 | response to thyroid hormone (GO:0097066) | 2.81697326 |
| 139 | regulation of tolerance induction (GO:0002643) | 2.81658855 |
| 140 | monocyte chemotaxis (GO:0002548) | 2.80252933 |
| 141 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.79877308 |
| 142 | regulation of interleukin-12 production (GO:0032655) | 2.78617186 |
| 143 | negative regulation of interleukin-17 production (GO:0032700) | 2.78414000 |
| 144 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.77593550 |
| 145 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.77148060 |
| 146 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.75713150 |
| 147 | regulation of chemokine biosynthetic process (GO:0045073) | 2.75006738 |
| 148 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.74239154 |
| 149 | N-acetylneuraminate metabolic process (GO:0006054) | 2.73195512 |
| 150 | cellular response to type I interferon (GO:0071357) | 2.72828572 |
| 151 | type I interferon signaling pathway (GO:0060337) | 2.72828572 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.69530025 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.15994504 |
| 3 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.75969090 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.70555947 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.55037385 |
| 6 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.54575833 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.33186992 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.07747189 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.00694325 |
| 10 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.99475101 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.81251112 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.67103783 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.65766254 |
| 14 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.64616896 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.54889380 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.49208659 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.36608645 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.27271964 |
| 19 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.20720494 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.19469931 |
| 21 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.12903039 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.04190342 |
| 23 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.97040874 |
| 24 | MYC_22102868_ChIP-Seq_BL_Human | 1.90812549 |
| 25 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.90701266 |
| 26 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.87579629 |
| 27 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.82784532 |
| 28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.77395635 |
| 29 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.76844380 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 1.75060645 |
| 31 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.71474592 |
| 32 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71248122 |
| 33 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.69400967 |
| 34 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.67716528 |
| 35 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.66986784 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.65301691 |
| 37 | MYB_26560356_Chip-Seq_TH2_Human | 1.63975552 |
| 38 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.60770490 |
| 39 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.60734433 |
| 40 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.59366292 |
| 41 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.58232941 |
| 42 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.54826773 |
| 43 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.54628939 |
| 44 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.54363653 |
| 45 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.53391581 |
| 46 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.51544342 |
| 47 | UTX_26944678_Chip-Seq_JUKART_Human | 1.50627940 |
| 48 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.50608136 |
| 49 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.50062884 |
| 50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.49855458 |
| 51 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.49216360 |
| 52 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.48928843 |
| 53 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.48738270 |
| 54 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.45684472 |
| 55 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.45525379 |
| 56 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.44411349 |
| 57 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.44185555 |
| 58 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.42728539 |
| 59 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.41547172 |
| 60 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.41383699 |
| 61 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.41140040 |
| 62 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40172110 |
| 63 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.38509240 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.36825637 |
| 65 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.35801352 |
| 66 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29909723 |
| 67 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27444731 |
| 68 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.26756018 |
| 69 | MYB_26560356_Chip-Seq_TH1_Human | 1.26383967 |
| 70 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25262479 |
| 71 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23679047 |
| 72 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.21451067 |
| 73 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20035252 |
| 74 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.19701290 |
| 75 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19659096 |
| 76 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.18856320 |
| 77 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.18688498 |
| 78 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17818095 |
| 79 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13527748 |
| 80 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13414159 |
| 81 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12581567 |
| 82 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.12534467 |
| 83 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11624565 |
| 84 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.11347006 |
| 85 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10954950 |
| 86 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10883154 |
| 87 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.08551496 |
| 88 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.08505686 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08178950 |
| 90 | MAF_26560356_Chip-Seq_TH2_Human | 1.06835805 |
| 91 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04670969 |
| 92 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.04618067 |
| 93 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01891757 |
| 94 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01141253 |
| 95 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.00665584 |
| 96 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00511937 |
| 97 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.99647297 |
| 98 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98587137 |
| 99 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.97675167 |
| 100 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.97570281 |
| 101 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97401715 |
| 102 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94873473 |
| 103 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92581088 |
| 104 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91679253 |
| 105 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.90952240 |
| 106 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.87159524 |
| 107 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.87132455 |
| 108 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.86890818 |
| 109 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.83666333 |
| 110 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.80701403 |
| 111 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.79894221 |
| 112 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.79788507 |
| 113 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.79477894 |
| 114 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.78265264 |
| 115 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.77339638 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 3.91771666 |
| 2 | MP0003436_decreased_susceptibility_to | 3.89494501 |
| 3 | MP0003303_peritoneal_inflammation | 3.66199480 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 3.65778765 |
| 5 | MP0002419_abnormal_innate_immunity | 2.95885874 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 2.90320163 |
| 7 | MP0009840_abnormal_foam_cell | 2.63000818 |
| 8 | MP0001533_abnormal_skeleton_physiology | 2.59142560 |
| 9 | MP0005387_immune_system_phenotype | 2.53501719 |
| 10 | MP0001790_abnormal_immune_system | 2.53501719 |
| 11 | MP0003724_increased_susceptibility_to | 2.51888037 |
| 12 | MP0005025_abnormal_response_to | 2.48752643 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.47558664 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.45378192 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.42797804 |
| 16 | MP0000685_abnormal_immune_system | 2.30479296 |
| 17 | MP0005464_abnormal_platelet_physiology | 2.26039945 |
| 18 | MP0004510_myositis | 2.21107216 |
| 19 | MP0003172_abnormal_lysosome_physiology | 2.18018684 |
| 20 | MP0003566_abnormal_cell_adhesion | 2.11097875 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.07768378 |
| 22 | MP0009278_abnormal_bone_marrow | 2.06940783 |
| 23 | MP0003075_altered_response_to | 2.03995243 |
| 24 | MP0004947_skin_inflammation | 2.00708167 |
| 25 | MP0003300_gastrointestinal_ulcer | 1.96900313 |
| 26 | MP0000343_altered_response_to | 1.93899740 |
| 27 | MP0001800_abnormal_humoral_immune | 1.90516639 |
| 28 | MP0009785_altered_susceptibility_to | 1.86199844 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.81179430 |
| 30 | MP0001851_eye_inflammation | 1.79549062 |
| 31 | MP0002420_abnormal_adaptive_immunity | 1.78179246 |
| 32 | MP0002405_respiratory_system_inflammati | 1.77580738 |
| 33 | MP0001819_abnormal_immune_cell | 1.76608351 |
| 34 | MP0005451_abnormal_body_composition | 1.76047201 |
| 35 | MP0006082_CNS_inflammation | 1.74816511 |
| 36 | MP0000465_gastrointestinal_hemorrhage | 1.73737122 |
| 37 | MP0002723_abnormal_immune_serum | 1.67515385 |
| 38 | MP0000604_amyloidosis | 1.66065928 |
| 39 | MP0002933_joint_inflammation | 1.60562764 |
| 40 | MP0003656_abnormal_erythrocyte_physiolo | 1.59987394 |
| 41 | MP0001845_abnormal_inflammatory_respons | 1.52371392 |
| 42 | MP0003448_altered_tumor_morphology | 1.50648865 |
| 43 | MP0008260_abnormal_autophagy | 1.47238279 |
| 44 | MP0002396_abnormal_hematopoietic_system | 1.45885319 |
| 45 | MP0005023_abnormal_wound_healing | 1.45247284 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.44266218 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.44266218 |
| 48 | MP0003191_abnormal_cellular_cholesterol | 1.43449911 |
| 49 | MP0005390_skeleton_phenotype | 1.43385879 |
| 50 | MP0003279_aneurysm | 1.41753693 |
| 51 | MP0005076_abnormal_cell_differentiation | 1.38651926 |
| 52 | MP0002139_abnormal_hepatobiliary_system | 1.37250225 |
| 53 | MP0000716_abnormal_immune_system | 1.34883912 |
| 54 | MP0005167_abnormal_blood-brain_barrier | 1.32147477 |
| 55 | MP0000689_abnormal_spleen_morphology | 1.31416826 |
| 56 | MP0002166_altered_tumor_susceptibility | 1.29564070 |
| 57 | MP0002398_abnormal_bone_marrow | 1.26868157 |
| 58 | MP0001958_emphysema | 1.22061353 |
| 59 | MP0003690_abnormal_glial_cell | 1.20255847 |
| 60 | MP0004808_abnormal_hematopoietic_stem | 1.19330422 |
| 61 | MP0000767_abnormal_smooth_muscle | 1.18500426 |
| 62 | MP0002429_abnormal_blood_cell | 1.17554929 |
| 63 | MP0008469_abnormal_protein_level | 1.16137079 |
| 64 | MP0003806_abnormal_nucleotide_metabolis | 1.15137506 |
| 65 | MP0002722_abnormal_immune_system | 1.15047139 |
| 66 | MP0003828_pulmonary_edema | 1.14363944 |
| 67 | MP0001853_heart_inflammation | 1.14122661 |
| 68 | MP0002254_reproductive_system_inflammat | 1.13120575 |
| 69 | MP0010307_abnormal_tumor_latency | 1.12281641 |
| 70 | MP0002998_abnormal_bone_remodeling | 1.11479651 |
| 71 | MP0003183_abnormal_peptide_metabolism | 1.11378205 |
| 72 | MP0000249_abnormal_blood_vessel | 1.11086417 |
| 73 | MP0000569_abnormal_digit_pigmentation | 1.09690130 |
| 74 | MP0003453_abnormal_keratinocyte_physiol | 1.09654008 |
| 75 | MP0005166_decreased_susceptibility_to | 1.03763956 |
| 76 | MP0010352_gastrointestinal_tract_polyps | 1.03215317 |
| 77 | MP0001915_intracranial_hemorrhage | 1.02603535 |
| 78 | MP0004883_abnormal_blood_vessel | 1.01304673 |
| 79 | MP0001849_ear_inflammation | 1.01167152 |
| 80 | MP0010155_abnormal_intestine_physiology | 0.99760364 |
| 81 | MP0003329_amyloid_beta_deposits | 0.99094675 |
| 82 | MP0005310_abnormal_salivary_gland | 0.97088973 |
| 83 | MP0009763_increased_sensitivity_to | 0.96264173 |
| 84 | MP0005174_abnormal_tail_pigmentation | 0.96214745 |
| 85 | MP0000490_abnormal_crypts_of | 0.94823696 |
| 86 | MP0003091_abnormal_cell_migration | 0.93554766 |
| 87 | MP0005671_abnormal_response_to | 0.93470669 |
| 88 | MP0005275_abnormal_skin_tensile | 0.91399869 |
| 89 | MP0002006_tumorigenesis | 0.90988938 |
| 90 | MP0000858_altered_metastatic_potential | 0.90910640 |
| 91 | MP0006054_spinal_hemorrhage | 0.89114856 |
| 92 | MP0001542_abnormal_bone_strength | 0.84937542 |
| 93 | MP0002332_abnormal_exercise_endurance | 0.83405149 |
| 94 | MP0003763_abnormal_thymus_physiology | 0.82472025 |
| 95 | MP0003795_abnormal_bone_structure | 0.75847468 |
| 96 | MP0005164_abnormal_response_to | 0.74492482 |
| 97 | MP0001614_abnormal_blood_vessel | 0.70676539 |
| 98 | MP0004185_abnormal_adipocyte_glucose | 0.69535398 |
| 99 | MP0009765_abnormal_xenobiotic_induced | 0.69148746 |
| 100 | MP0002138_abnormal_hepatobiliary_system | 0.67748544 |
| 101 | MP0000733_abnormal_muscle_development | 0.66531897 |
| 102 | MP0002877_abnormal_melanocyte_morpholog | 0.65831541 |
| 103 | MP0000371_diluted_coat_color | 0.65082000 |
| 104 | MP0005647_abnormal_sex_gland | 0.64589239 |
| 105 | MP0001663_abnormal_digestive_system | 0.64489465 |
| 106 | MP0000750_abnormal_muscle_regeneration | 0.61171080 |
| 107 | MP0010630_abnormal_cardiac_muscle | 0.60711522 |
| 108 | MP0008874_decreased_physiological_sensi | 0.60457322 |
| 109 | MP0009764_decreased_sensitivity_to | 0.58962048 |
| 110 | MP0005165_increased_susceptibility_to | 0.57788748 |
| 111 | MP0001873_stomach_inflammation | 0.57660936 |
| 112 | MP0008004_abnormal_stomach_pH | 0.57400249 |
| 113 | MP0004272_abnormal_basement_membrane | 0.57262326 |
| 114 | MP0002060_abnormal_skin_morphology | 0.56624427 |
| 115 | MP0002128_abnormal_blood_circulation | 0.56613441 |
| 116 | MP0000920_abnormal_myelination | 0.56524663 |
| 117 | MP0000015_abnormal_ear_pigmentation | 0.55845359 |
| 118 | MP0009931_abnormal_skin_appearance | 0.55378419 |
| 119 | MP0005319_abnormal_enzyme/_coenzyme | 0.53412623 |
| 120 | MP0009115_abnormal_fat_cell | 0.52815826 |
| 121 | MP0003195_calcinosis | 0.51063914 |
| 122 | MP0005595_abnormal_vascular_smooth | 0.50416276 |
| 123 | MP0002277_abnormal_respiratory_mucosa | 0.50343227 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 8.50801810 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.94960592 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.31640693 |
| 4 | Glomerulonephritis (HP:0000099) | 5.17140997 |
| 5 | Eczematoid dermatitis (HP:0000976) | 5.14553779 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 5.07644118 |
| 7 | Dysostosis multiplex (HP:0000943) | 4.82583887 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 4.79472333 |
| 9 | Abnormality of complement system (HP:0005339) | 4.36508066 |
| 10 | Abnormality of macrophages (HP:0004311) | 3.89449164 |
| 11 | Mucopolysacchariduria (HP:0008155) | 3.88556553 |
| 12 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.88556553 |
| 13 | Spondylolisthesis (HP:0003302) | 3.83682136 |
| 14 | Retrobulbar optic neuritis (HP:0100654) | 3.79461214 |
| 15 | Optic neuritis (HP:0100653) | 3.79461214 |
| 16 | Increased cerebral lipofuscin (HP:0011813) | 3.78824780 |
| 17 | Complement deficiency (HP:0004431) | 3.75059143 |
| 18 | Stomatitis (HP:0010280) | 3.72467255 |
| 19 | Shallow orbits (HP:0000586) | 3.66971748 |
| 20 | Peritonitis (HP:0002586) | 3.64733299 |
| 21 | Cervical subluxation (HP:0003308) | 3.61619046 |
| 22 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.60325387 |
| 23 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.60325387 |
| 24 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.60325387 |
| 25 | Asymmetric septal hypertrophy (HP:0001670) | 3.56686061 |
| 26 | Loss of speech (HP:0002371) | 3.44070089 |
| 27 | Pustule (HP:0200039) | 3.41465462 |
| 28 | J-shaped sella turcica (HP:0002680) | 3.41165752 |
| 29 | Mutism (HP:0002300) | 3.33894806 |
| 30 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.18757664 |
| 31 | Nephritis (HP:0000123) | 3.16923202 |
| 32 | Gingivitis (HP:0000230) | 3.15466210 |
| 33 | Autoimmune thrombocytopenia (HP:0001973) | 3.15156003 |
| 34 | Amyloidosis (HP:0011034) | 3.07800032 |
| 35 | Cerebral aneurysm (HP:0004944) | 3.04273877 |
| 36 | Wrist flexion contracture (HP:0001239) | 3.04152333 |
| 37 | Abnormality of the lumbar spine (HP:0100712) | 2.93686896 |
| 38 | Nasal polyposis (HP:0100582) | 2.92405742 |
| 39 | Cellulitis (HP:0100658) | 2.83483691 |
| 40 | Joint stiffness (HP:0001387) | 2.80992226 |
| 41 | Deformed sella turcica (HP:0002681) | 2.79072001 |
| 42 | Chronic obstructive pulmonary disease (HP:0006510) | 2.77217340 |
| 43 | Obstructive lung disease (HP:0006536) | 2.77217340 |
| 44 | Thoracic kyphosis (HP:0002942) | 2.77165076 |
| 45 | Mediastinal lymphadenopathy (HP:0100721) | 2.76716792 |
| 46 | Myocardial infarction (HP:0001658) | 2.76109331 |
| 47 | Recurrent skin infections (HP:0001581) | 2.75502863 |
| 48 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.74369060 |
| 49 | Periodontitis (HP:0000704) | 2.72889559 |
| 50 | Axonal loss (HP:0003447) | 2.72483738 |
| 51 | Prolonged bleeding time (HP:0003010) | 2.72349436 |
| 52 | Neurofibrillary tangles (HP:0002185) | 2.71468136 |
| 53 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.69519449 |
| 54 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.69519449 |
| 55 | Abnormality of glycolipid metabolism (HP:0010969) | 2.69519449 |
| 56 | Abnormality of the nasal mucosa (HP:0000433) | 2.66681004 |
| 57 | Keratoconjunctivitis sicca (HP:0001097) | 2.66299673 |
| 58 | Menorrhagia (HP:0000132) | 2.65626117 |
| 59 | Petechiae (HP:0000967) | 2.64460566 |
| 60 | Pulmonary infiltrates (HP:0002113) | 2.62782748 |
| 61 | Osteolytic defects of the hand bones (HP:0009699) | 2.62131272 |
| 62 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.62131272 |
| 63 | Disinhibition (HP:0000734) | 2.61483978 |
| 64 | Hemoptysis (HP:0002105) | 2.60616771 |
| 65 | Increased serum ferritin (HP:0003281) | 2.55226669 |
| 66 | Myositis (HP:0100614) | 2.55136450 |
| 67 | Meningitis (HP:0001287) | 2.49834767 |
| 68 | Recurrent fungal infections (HP:0002841) | 2.46076236 |
| 69 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.44864970 |
| 70 | Recurrent cutaneous fungal infections (HP:0011370) | 2.44864970 |
| 71 | Nuclear cataract (HP:0100018) | 2.43580966 |
| 72 | Vasculitis (HP:0002633) | 2.42758584 |
| 73 | Keratoconjunctivitis (HP:0001096) | 2.41612823 |
| 74 | Neuronal loss in central nervous system (HP:0002529) | 2.37878052 |
| 75 | Hepatosplenomegaly (HP:0001433) | 2.37391492 |
| 76 | Upper motor neuron abnormality (HP:0002127) | 2.37359443 |
| 77 | Orchitis (HP:0100796) | 2.32472201 |
| 78 | Gastrointestinal infarctions (HP:0005244) | 2.29266247 |
| 79 | Spontaneous hematomas (HP:0007420) | 2.28898551 |
| 80 | Arterial tortuosity (HP:0005116) | 2.28800418 |
| 81 | Vertebral compression fractures (HP:0002953) | 2.27284359 |
| 82 | Progressive neurologic deterioration (HP:0002344) | 2.24207699 |
| 83 | Agnosia (HP:0010524) | 2.21961664 |
| 84 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.21216230 |
| 85 | Abnormality of the thoracic spine (HP:0100711) | 2.21040446 |
| 86 | Urticaria (HP:0001025) | 2.20301477 |
| 87 | Inappropriate behavior (HP:0000719) | 2.18943142 |
| 88 | Beaking of vertebral bodies (HP:0004568) | 2.18807706 |
| 89 | Polyneuropathy (HP:0001271) | 2.18332556 |
| 90 | Prostate neoplasm (HP:0100787) | 2.17313243 |
| 91 | Hand muscle atrophy (HP:0009130) | 2.17232182 |
| 92 | T lymphocytopenia (HP:0005403) | 2.14501743 |
| 93 | Broad metatarsal (HP:0001783) | 2.13110978 |
| 94 | Encephalitis (HP:0002383) | 2.11209518 |
| 95 | Polygenic inheritance (HP:0010982) | 2.09338986 |
| 96 | Increased IgE level (HP:0003212) | 2.09241938 |
| 97 | Epistaxis (HP:0000421) | 2.08316554 |
| 98 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.06364044 |
| 99 | Ovoid vertebral bodies (HP:0003300) | 2.05553854 |
| 100 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.05348987 |
| 101 | Short nail (HP:0001799) | 2.04527959 |
| 102 | Arterial thrombosis (HP:0004420) | 2.04507890 |
| 103 | Vascular tortuosity (HP:0004948) | 2.04195576 |
| 104 | Abnormality of iron homeostasis (HP:0011031) | 2.04105443 |
| 105 | Increased density of long bones (HP:0006392) | 2.02942127 |
| 106 | Chronic otitis media (HP:0000389) | 2.01539177 |
| 107 | Metaphyseal irregularity (HP:0003025) | 1.99052088 |
| 108 | Cerebral inclusion bodies (HP:0100314) | 1.98913599 |
| 109 | Basal ganglia calcification (HP:0002135) | 1.98453033 |
| 110 | Abnormality of the sella turcica (HP:0002679) | 1.98180225 |
| 111 | Arthropathy (HP:0003040) | 1.97417896 |
| 112 | Pathologic fracture (HP:0002756) | 1.97184628 |
| 113 | Abnormal platelet function (HP:0011869) | 1.96212051 |
| 114 | Impaired platelet aggregation (HP:0003540) | 1.96212051 |
| 115 | Distal upper limb amyotrophy (HP:0007149) | 1.95686940 |
| 116 | Upper limb amyotrophy (HP:0009129) | 1.95686940 |
| 117 | Episodic fever (HP:0001954) | 1.95351159 |
| 118 | Absent frontal sinuses (HP:0002688) | 1.94320899 |
| 119 | Abnormality of T cell number (HP:0011839) | 1.93912702 |
| 120 | Gingival bleeding (HP:0000225) | 1.93134100 |
| 121 | Enlarged penis (HP:0000040) | 1.93012010 |
| 122 | Chest pain (HP:0100749) | 1.91061420 |
| 123 | Pulmonary embolism (HP:0002204) | 1.90366395 |
| 124 | Hematochezia (HP:0002573) | 1.90066950 |
| 125 | Premature rupture of membranes (HP:0001788) | 1.87723349 |
| 126 | Abnormality of the peritoneum (HP:0002585) | 1.87390386 |
| 127 | Gangrene (HP:0100758) | 1.87029567 |
| 128 | Personality changes (HP:0000751) | 1.85918144 |
| 129 | Hypoplasia of the odontoid process (HP:0003311) | 1.85879319 |
| 130 | Vertigo (HP:0002321) | 1.84153110 |
| 131 | Recurrent viral infections (HP:0004429) | 1.83526914 |
| 132 | Leukocytosis (HP:0001974) | 1.83075738 |
| 133 | Conjunctival telangiectasia (HP:0000524) | 1.82452051 |
| 134 | Osteomyelitis (HP:0002754) | 1.82432642 |
| 135 | Coarse hair (HP:0002208) | 1.82238219 |
| 136 | Malnutrition (HP:0004395) | 1.81578828 |
| 137 | Interstitial pulmonary disease (HP:0006530) | 1.81310761 |
| 138 | Premature loss of primary teeth (HP:0006323) | 1.80946002 |
| 139 | Abnormality of the periventricular white matter (HP:0002518) | 1.80872171 |
| 140 | Colitis (HP:0002583) | 1.80671168 |
| 141 | Global brain atrophy (HP:0002283) | 1.80361136 |
| 142 | Abnormality of the odontoid process (HP:0003310) | 1.79968046 |
| 143 | Dementia (HP:0000726) | 1.79944135 |
| 144 | Poor head control (HP:0002421) | 1.79943652 |
| 145 | Diminished motivation (HP:0000745) | 1.79692447 |
| 146 | Apathy (HP:0000741) | 1.77937058 |
| 147 | Purpura (HP:0000979) | 1.77219324 |
| 148 | Broad face (HP:0000283) | 1.77210080 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 4.08068066 |
| 2 | MST1R | 4.04415628 |
| 3 | TRIB3 | 3.71608373 |
| 4 | PKN2 | 3.29927477 |
| 5 | ERN1 | 3.16618069 |
| 6 | MAP4K1 | 2.75665324 |
| 7 | CAMK1D | 2.69048534 |
| 8 | PRPF4B | 2.57663270 |
| 9 | EPHB1 | 2.52449422 |
| 10 | GRK7 | 2.45170654 |
| 11 | TTN | 2.44230176 |
| 12 | RIPK1 | 2.26154763 |
| 13 | TAOK3 | 2.23160691 |
| 14 | RIPK4 | 2.15780443 |
| 15 | BMX | 2.06662973 |
| 16 | TAOK2 | 2.05684462 |
| 17 | KIT | 2.00752626 |
| 18 | TYK2 | 1.97069443 |
| 19 | CAMK1G | 1.95120149 |
| 20 | IRAK4 | 1.93699849 |
| 21 | TBK1 | 1.86884548 |
| 22 | STK10 | 1.85550224 |
| 23 | DDR2 | 1.82424953 |
| 24 | FES | 1.79851014 |
| 25 | TAOK1 | 1.62707179 |
| 26 | MAP2K3 | 1.59941590 |
| 27 | MET | 1.55647038 |
| 28 | EEF2K | 1.52080681 |
| 29 | LRRK2 | 1.51490377 |
| 30 | FGR | 1.47313370 |
| 31 | PTK6 | 1.46158958 |
| 32 | CSK | 1.42719705 |
| 33 | BTK | 1.40002964 |
| 34 | HCK | 1.38727969 |
| 35 | CDC42BPA | 1.38666311 |
| 36 | GRK6 | 1.36838290 |
| 37 | ZAP70 | 1.36716448 |
| 38 | TGFBR2 | 1.35904026 |
| 39 | TRPM7 | 1.26718599 |
| 40 | MAP3K11 | 1.26033162 |
| 41 | BMPR2 | 1.22963802 |
| 42 | CSF1R | 1.17513002 |
| 43 | CLK1 | 1.15236020 |
| 44 | DAPK2 | 1.05307064 |
| 45 | RPS6KA4 | 1.04103089 |
| 46 | ACVR1B | 1.00999292 |
| 47 | JAK3 | 0.98653543 |
| 48 | MAP3K14 | 0.95038123 |
| 49 | SYK | 0.94391283 |
| 50 | IRAK2 | 0.93146737 |
| 51 | NME2 | 0.93076737 |
| 52 | SCYL2 | 0.92490873 |
| 53 | JAK1 | 0.90160735 |
| 54 | MAP3K13 | 0.90105917 |
| 55 | MAP3K5 | 0.88711226 |
| 56 | LCK | 0.87772646 |
| 57 | TNK2 | 0.86775425 |
| 58 | MAP3K10 | 0.85231163 |
| 59 | MARK3 | 0.85195110 |
| 60 | STK24 | 0.84211726 |
| 61 | IKBKB | 0.83871657 |
| 62 | IRAK1 | 0.83688131 |
| 63 | MATK | 0.83639752 |
| 64 | TEC | 0.82245881 |
| 65 | JAK2 | 0.80910768 |
| 66 | CAMKK2 | 0.80699925 |
| 67 | CAMKK1 | 0.79693569 |
| 68 | PAK4 | 0.78498112 |
| 69 | CDK6 | 0.76261685 |
| 70 | ADRBK2 | 0.75984477 |
| 71 | PRKCH | 0.75688880 |
| 72 | LYN | 0.74994595 |
| 73 | TESK2 | 0.74305026 |
| 74 | MAPK7 | 0.71280921 |
| 75 | CHUK | 0.71258738 |
| 76 | SIK2 | 0.71052781 |
| 77 | RPS6KA6 | 0.67168789 |
| 78 | ILK | 0.66314863 |
| 79 | SIK3 | 0.65512450 |
| 80 | RPS6KC1 | 0.63250285 |
| 81 | RPS6KL1 | 0.63250285 |
| 82 | DAPK3 | 0.62581493 |
| 83 | MARK2 | 0.62397673 |
| 84 | EGFR | 0.62347931 |
| 85 | KSR2 | 0.61466773 |
| 86 | IRAK3 | 0.60624903 |
| 87 | MAPKAPK2 | 0.59616607 |
| 88 | MAP3K3 | 0.58951728 |
| 89 | STK4 | 0.58550951 |
| 90 | PIM1 | 0.57589678 |
| 91 | RPS6KA2 | 0.56666838 |
| 92 | NEK9 | 0.56626693 |
| 93 | PIM2 | 0.55820655 |
| 94 | DMPK | 0.55694803 |
| 95 | MAPK12 | 0.55603371 |
| 96 | FLT3 | 0.54656908 |
| 97 | IKBKE | 0.54184265 |
| 98 | STK3 | 0.53246306 |
| 99 | TESK1 | 0.51973025 |
| 100 | PDPK1 | 0.49784543 |
| 101 | MAP3K8 | 0.49772081 |
| 102 | FYN | 0.49545574 |
| 103 | MAP2K6 | 0.49428759 |
| 104 | PTK2B | 0.48373724 |
| 105 | NEK2 | 0.47247496 |
| 106 | MAP3K6 | 0.46912191 |
| 107 | TXK | 0.44346012 |
| 108 | ARAF | 0.44087183 |
| 109 | LIMK1 | 0.43728274 |
| 110 | ABL2 | 0.43454147 |
| 111 | MAPK4 | 0.42945566 |
| 112 | ABL1 | 0.41415391 |
| 113 | MOS | 0.41026365 |
| 114 | IGF1R | 0.40297884 |
| 115 | PDGFRB | 0.39796228 |
| 116 | MAPKAPK5 | 0.39561097 |
| 117 | PIK3CG | 0.39281278 |
| 118 | PDK2 | 0.39158394 |
| 119 | KDR | 0.38855313 |
| 120 | PRKD2 | 0.36910363 |
| 121 | PDK1 | 0.35849260 |
| 122 | MAPKAPK3 | 0.35652264 |
| 123 | DAPK1 | 0.35615702 |
| 124 | TYRO3 | 0.35522536 |
| 125 | PRKCD | 0.35275492 |
| 126 | YES1 | 0.34787286 |
| 127 | FGFR1 | 0.33714942 |
| 128 | ITK | 0.33379623 |
| 129 | ALK | 0.32405971 |
| 130 | MAP3K1 | 0.31996445 |
| 131 | HIPK2 | 0.31849500 |
| 132 | SGK3 | 0.31692797 |
| 133 | CAMK4 | 0.27761462 |
| 134 | CDK4 | 0.26883855 |
| 135 | EPHA3 | 0.25926348 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 6.20152168 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 4.59193138 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.75948108 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 3.18279903 |
| 5 | Pertussis_Homo sapiens_hsa05133 | 2.98387813 |
| 6 | Lysosome_Homo sapiens_hsa04142 | 2.64038305 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.58187303 |
| 8 | Malaria_Homo sapiens_hsa05144 | 2.38729930 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.37785324 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.21465743 |
| 11 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.12021105 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.10126365 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.00146341 |
| 14 | Legionellosis_Homo sapiens_hsa05134 | 1.98491199 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 1.82011804 |
| 16 | Phagosome_Homo sapiens_hsa04145 | 1.81153493 |
| 17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.76561126 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.67101509 |
| 19 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.53543550 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.51641059 |
| 21 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.49527359 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.48210208 |
| 23 | Amoebiasis_Homo sapiens_hsa05146 | 1.47252200 |
| 24 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.45309627 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.42501896 |
| 26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.42262029 |
| 27 | Shigellosis_Homo sapiens_hsa05131 | 1.32945049 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30783840 |
| 29 | Salmonella infection_Homo sapiens_hsa05132 | 1.29693267 |
| 30 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.29310819 |
| 31 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.26609913 |
| 32 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.25049530 |
| 33 | Platelet activation_Homo sapiens_hsa04611 | 1.24346239 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.15802512 |
| 35 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.13270144 |
| 36 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.13247841 |
| 37 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.09532154 |
| 38 | Prion diseases_Homo sapiens_hsa05020 | 1.07325545 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.07104536 |
| 40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.05031345 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.01952186 |
| 42 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.00867745 |
| 43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.00480489 |
| 44 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.98408381 |
| 45 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.96703681 |
| 46 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.95435946 |
| 47 | Measles_Homo sapiens_hsa05162 | 0.95003241 |
| 48 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.94066695 |
| 49 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.93761213 |
| 50 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.92942786 |
| 51 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.92801515 |
| 52 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.92558004 |
| 53 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.91487105 |
| 54 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.87846190 |
| 55 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.87487454 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.87073120 |
| 57 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.87032583 |
| 58 | Asthma_Homo sapiens_hsa05310 | 0.84675673 |
| 59 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.82483706 |
| 60 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.79310636 |
| 61 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.79102908 |
| 62 | Influenza A_Homo sapiens_hsa05164 | 0.78385697 |
| 63 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.77263515 |
| 64 | Hepatitis B_Homo sapiens_hsa05161 | 0.76508001 |
| 65 | Focal adhesion_Homo sapiens_hsa04510 | 0.76503644 |
| 66 | Bladder cancer_Homo sapiens_hsa05219 | 0.76023755 |
| 67 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.70038018 |
| 68 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.68234530 |
| 69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66373562 |
| 70 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.65886871 |
| 71 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.65243139 |
| 72 | Endocytosis_Homo sapiens_hsa04144 | 0.64579907 |
| 73 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.63901553 |
| 74 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.63706372 |
| 75 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63029371 |
| 76 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.62167024 |
| 77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59164504 |
| 78 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.56867611 |
| 79 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.55833876 |
| 80 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.51384443 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50748034 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49474805 |
| 83 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49380734 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48210180 |
| 85 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46670995 |
| 86 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46517565 |
| 87 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46209981 |
| 88 | Hepatitis C_Homo sapiens_hsa05160 | 0.46023021 |
| 89 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45544031 |
| 90 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45030432 |
| 91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44346225 |
| 92 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.44133820 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43842986 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42230573 |
| 95 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41555577 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.41339384 |
| 97 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.40997363 |
| 98 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.40782078 |
| 99 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.40373207 |
| 100 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39894314 |
| 101 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39573213 |
| 102 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.37675545 |
| 103 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.37666811 |
| 104 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.37357841 |
| 105 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.36394133 |
| 106 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.35995790 |
| 107 | Mineral absorption_Homo sapiens_hsa04978 | 0.35594653 |
| 108 | HTLV-I infection_Homo sapiens_hsa05166 | 0.33093612 |
| 109 | Adherens junction_Homo sapiens_hsa04520 | 0.32366014 |
| 110 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.30680597 |
| 111 | Colorectal cancer_Homo sapiens_hsa05210 | 0.29346012 |
| 112 | Pathways in cancer_Homo sapiens_hsa05200 | 0.29258112 |
| 113 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.29072283 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28937317 |
| 115 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.28568363 |
| 116 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.28525225 |
| 117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28446833 |
| 118 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.27354692 |
| 119 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.26978611 |
| 120 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.26406210 |
| 121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.26182196 |
| 122 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.25169002 |
| 123 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.22710139 |
| 124 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.21566574 |

